NAME

Question types


Start with


Question limit

of 72 available terms
(1 exact duplicate found)

Advertisement Upgrade to remove ads
Print test

5 Written questions

5 Matching questions

  1. PENICILLIN G or V Contraindications -
  2. AUGMENTIN (Amoxicillin/Clavulanate) Use
  3. CEFUROXIME Contraindictions -
  4. CEFTRIAXONE Contraindictions -
  5. PENICILLIN G or V Nursing Implications
  1. a Previous hypersensitivity to penicillin
  2. b - Administer IV / IM = Penicillin G; PO = Penicillin V ; Observe for s/s anaphalxis
  3. c Hypersensitivity to cephalosporins.
    • Serious hypersensitivity to penicillins.
    • Pedi: Neonates 28 days (use in hyperbilirubinemic neonates may lead to kernicterus).
    • Pedi: Neonates 28 days requiring calcium-containing IV solutions ( risk of precipitation formation).
  4. d Hypersensitivity to cephalosporins. Serious hypersensitivity to penicillins
  5. e Skin and skin structure infection Otitis media, Sinusitis Respiratory tract infections, Genitourinary tract infections.

5 Multiple choice questions

  1. Contraindictions - Hypersensitivity to cephalosporins, Serious hypersensitivity to penicillins
  2. ataxia, vertigo, ototoxicity(vestibulare & cochlear) nephrotoxiticy, muscle paralysis(high parenteral doses); hybersensitivyt reactions
  3. Action - Binds to bacterial cell wall membrane, causing cell death; Bactericidal action against susceptible bacteria; Active against many gram-positive cocci including
  4. Nursing implications- IV; IM; Intermittent infusion
  5. Hypersensitivity (cross-sensitivity within class may exist).
    • OB: Do not use unless potential benefit outweighs potential fetal risk.
    • Pedi: Use only for treatment of anthrax and complicated urinary tract infections in children 1-17 years due to possible arthropathy

5 True/False questions

  1. Pencillin G / V UsePneumocoocal pneumonia; streptoccocal pharyngitis, syphilis, Gonorrhea strains, enterococcal infection; Prevention of rheumatic fever

          

  2. CIPROFLOXACINAction - Inhibits bacterial DNA synthesis by inhibiting DNA gyrase enzyme.; Death of susceptible bacteria; Active against gram-positive pathogens, including. › Staphylococcus aureus.
    › Staphylococcus epidermidis.
    › Staphylococcus saprophyticus.
    › Streptococcus pyogenes.
    › Streptococcus pneumoniae.
    › Enterococcus faecalis.
    › Bacillus anthracis (anthrax).
    • Gram-negative spectrum notable for activity against. › Escherichia coli.
    › Klebsiella pneumoniae.
    › Enterobacter cloacae.
    › Salmonella typhi.
    › Shigella spp.
    › Proteus mirabilis.
    › Proteus vulgaris.
    › Providencia stuartii.
    › Providencia rettgeri.
    › Morganella morganii.
    › Pseudomonas aeruginosa.
    › Serratia marcescens.
    › Haemophilus influenzae.
    › Neisseria gonorrhoeae.
    › Moraxella catarrhalis.
    › Campylobacter jejuni.

    Use- PO, IV: Treatment of the following bacterial infections. › Urinary tract and gynecologic infections, including cystitis, gonorrhea, and prostatitis.
    › Respiratory tract infections including acute sinusitis, acute exacerbations of chronic bronchitis, and pneumonia.
    › Skin and skin structure infections .
    › Bone and joint infections .
    › Infectious diarrhea .
    › Complicated intra-abdominal infections (with metronidazole).
    › Typhoid fever.
    • Post-exposure prophylaxis of inhalational anthrax.
    • Cutaneous anthrax.

    Side Effect - Seizures, dizziness, drowsiness, headache, insomnia, agitation, confusion, d/n/r , pseudomembranous colitis, abdominal pain, abnormal liver enzymes, vaginitis, photosensitivity, hyperglycemia, hypoglycemia, eosinophilia, phlebitits at IV site, tendinitis, tendon rupture, peripheral neuropathy, anaphylaxis

    Contraindictions - Hypersensitivity (cross-sensitivity within class may exist).
    • OB: Do not use unless potential benefit outweighs potential fetal risk.
    • Pedi: Use only for treatment of anthrax and complicated urinary tract infections in children 1-17 years due to possible arthropathy.

    Nursing implications - PO on empty stomach ; intermittent infusion; observe for s/s of anayphylaxis, monitor bowel function

    Trade / Generic Name - Cipro, Cipro XR, Proquin XR

    Classification - Fluoroquinolones; anti-infectives

    Dosage: PO 500-750 mg q 12hrs
    IV 400 mg q 12 hrs

          

  3. AMOXICILLIN Action -Bind to bacterial cell wall, resulting in cell death; Broad spectrum

          

  4. CEFTRIAXONE side effects aresezures (High doses), pseudomembranous colitis, d/, cholelithaiasis, gallbladder sludging, rashes, urticaria, bleeding, eosinophilia, hemolytic anemia, leucopenia, thrombocytosis, pain @ IM site, phlebitis at IV site, anaphylaxis, superinfection

          

  5. PIPERACILLIN Contraindictions -Hypersensitivity to penicillins, beta-lactams, cephalosporins, or tazobactam (cross-sensitivity may occur

          

Create Set